Welcome to our dedicated page for Venus Concept news (Ticker: VERO), a resource for investors and traders seeking the latest updates and insights on Venus Concept stock.
Venus Concept Inc. (VERO) delivers innovative medical aesthetic and hair restoration technologies through its unique subscription-based model. This dedicated news hub provides investors and industry professionals with essential updates on corporate developments, product advancements, and strategic initiatives shaping the global aesthetics market.
Access real-time announcements including quarterly earnings reports, regulatory filings, technology launches, and partnership agreements. Our curated collection ensures you stay informed about VERO's minimally invasive treatment systems, international expansion efforts, and clinical research breakthroughs without promotional bias.
Key coverage areas include financial performance updates, new device approvals, practice support program enhancements, and market expansion activities. Each update is verified for accuracy and presented in clear, accessible language suitable for both professional investors and industry observers.
Bookmark this page for streamlined access to Venus Concept's evolving business narrative. Check regularly for authoritative reporting on how VERO continues integrating advanced technologies like radiofrequency systems and IPL platforms with practice growth initiatives across 60+ countries.
Venus Concept, a global leader in medical aesthetic technology, has regained compliance with Nasdaq's Minimum Equity Requirement as of June 4, 2024. The company was previously issued a deficiency notice on May 31, 2023, for not meeting the minimum stockholders' equity requirement of $2.5 million, as per their March 31, 2023, Quarterly Report. To rectify this, Venus Concept completed a $35 million debt-to-equity transaction on May 28, 2024. As a result, the company met the compliance requirements verified by Nasdaq. Venus Concept will be under mandatory panel monitoring until June 4, 2025, according to Nasdaq Listing Rule 5815(d)(4)(B).
Venus Concept announced that it received a medical device license from Health Canada for its Venus Versa Pro system.
The Venus Versa Pro is a comprehensive aesthetic platform that integrates IPL with SmartPulse™, NanoFractional Radio Frequency with SmartScan™, and Venus Concept's proprietary (MP)2 technology.
This device is designed to provide a range of skin rejuvenation treatments, including enhancing skin tone, improving tightness, and smoothing texture.
Dr. Hemanth Varghese, President and COO, emphasized the company's excitement about bringing this advanced technology to the Canadian market.
Venus Concept, a global medical aesthetic technology leader, announced a $35 million debt-to-equity exchange with Madryn Asset Management. On May 24, 2024, the company exchanged $35 million of senior debt for 576,986 shares of Series Y preferred stock, convertible into common stock on a 1-for-100 basis. This transaction reduced Venus Concept's debt from $76.7 million to $45.4 million and aimed to help the company comply with Nasdaq's equity listing standards. Venus Concept's CEO, Rajiv De Silva, stated that this move is part of ongoing restructuring to achieve cash flow breakeven in 2025 and long-term profitability.
Venus Concept (NASDAQ: VERO) announced its Q1 2024 financial results, reporting a 15% YoY revenue decline to $17.5 million, but exceeding its forecast by 6%. Operating expenses dropped 11% to $19.4 million, while the net loss was $9.8 million, slightly higher than Q1 2023's $9.7 million. The gross profit fell 15% to $11.6 million with a consistent gross margin of about 66.6%. Notably, cash operations used $2.9 million, a 51% reduction from the previous year. The company secured $5.0 million in debt financing from Madryn Asset Management to enhance near-term liquidity. Strategic milestones include the TGA clearance in Australia for Venus Versa Pro and approval for Venus Bliss MAX in Israel. Venus Concept forecasts Q2 2024 revenue to be at least $16.5 million.
FAQ
What is the current stock price of Venus Concept (VERO)?
What is the market cap of Venus Concept (VERO)?
